EYPT:NASDAQ
EyePoint Inc
၃.၄၀ US$
arrow_downward
-၁.၇၃%(-၀.၀၆၀) 1D
၃.၄၀ US$
၀.၀၀% (၀.၀၀)
bedtimeAfter hours
Closed: အောက် ၉, GMT-၄ ၁၆:၀၀:၀၁ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EYPT...
Open
၃.၄၄ US$
High
၃.၅၇ US$
Low
၃.၃၈ US$
Mkt. cap
၂၉.၃၁ ကုဋေ
Avg. vol.
၃.၅၂ သန်း
Volume
၁.၉၄ သန်း
52-wk high
၁၉.၀၁ US$
52-wk low
၃.၀၅ US$
EPS
-၃.၇၄ US$
Beta
၁.၆၇
Shares outstanding
၈.၆၂ ကုဋေ
No. of employees
၂၁၄
Open
၃.၄၄ US$
High
၃.၅၇ US$
Low
၃.၃၈ US$
Mkt. cap
၂၉.၃၁ ကုဋေ
Avg. vol.
၃.၅၂ သန်း
Volume
၁.၉၄ သန်း
52-wk high
၁၉.၀၁ US$
52-wk low
၃.၀၅ US$
EPS
-၃.၇၄ US$
Beta
၁.၆၇
Shares outstanding
၈.၆၂ ကုဋေ
No. of employees
၂၁၄
News stories
From web sources and news partners
TradingView
·
ပြီးခဲ့သည့် ၁ နာရီ
Retension Pharmaceuticals, Clinical-Stage Developer of Hypertension Therapies, Files for Nasdaq Capital Market IPO
MarketBeat
·
ပြီးခဲ့သည့် ၃ မိနစ်
Astera Labs (NASDAQ:ALAB) Director Sells $3,382,283.64 in Stock
TheStreet Pro
·
ပြီးခဲ့သည့် ၃၉ မိနစ်
A Broad Friday Rally Takes the S&P 500 Just Below Record Highs
Yahoo Finance
·
ပြီးခဲ့သည့် ၂ နာရီ
LB Pharmaceuticals Reports Inducement Grants to New Employee Under Nasdaq Listing Rule 5635(c)(4)
Profile
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc. Wikipedia
About EyePoint Inc
CEO-
Employees၂၁၄
Founded၂၀၀၀
HeadquartersWatertown, မက်ဆာချူးဆက်ပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websiteeyepoint.bio